The future graduate of the Master's Degree in design Galenic and Manufacturing in the Pharmaceutical Industry, Eider Arana (NHyD+Far 13), has taken over the award to the best poster in the issue 37 edition of International Symposium of the Spanish Industry Pharmacists association (AEFI).

This association is an entity that works for shaping and maintaining the technical environment of the drug through conference and sessionsThe future postgraduate explains. "Since its founding in 1977 - this year's motto is "Industry and AEFI: 40 years of sharing knowledge"- has had as goal to achieve recognition of the role and responsibility of the pharmacist in the industry, and of its training and constant update and innovation of knowledge. All this with the aim of achieving a high level of quality and safety in products that has a positive impact on the health of the population," says Eider.

20 round tables, 5 oral communications, 7 workshops and 23 posters

In this edition, the Symposium focused on the researchregistration, production, quality, pharmacovigilance, registration, production, quality, pharmacovigilance and new communication platforms. These topics were addressed in round tables, workshops, oral communications, posters and debates that took place at the end of each session to encourage the active participation of the attendees.

A total of 20 round tables, 5 oral communications, 7 workshops and 23 posters were presented at meeting . The students of the Master's Degree of design Galenic and Manufacturing in the Pharmaceutical Industry sent 4 posters. The poster graduate "Acetazolamide 500 mg lyophilized injectables" was awarded the prize for the best poster. best of the meeting.

The goal of the winning work , as explained by its author, Eider Arana, "was to design and manufacture a lyophilized sterile injectable with 500 mg/vial of acetazolamide, since this presentation does not currently exist for the indicated drug. This formulation has a number of advantages: being a lyophilized powder improves the stability of the product, and by modifying the volume of the reconstituent, the concentration of the drug could be adapted to different treatments with the administration of intravenous boluses". "Finally," adds the student at postgraduate program, "since the parenteral route is used, there would be greater bioavailability for the administration of acetazolamide in emergency cases."